Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins

Cancer Research

Volumn 68, Issue 3, 2008, Pages 808-814

  Gupta, Nupur ^a,b   Delrow, Jeffrey ^e   Drawid, Amar ^d,f   Sengupta, Anirvan M ^d   Fan, Gaofeng ^a,b   Gélinas, Céline ^a,c,g  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f SANOFI   (France)

^g CABM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CHIMERIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; TRANSCRIPTION FACTOR REL; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; B CELL ADAPTOR; B CELL LINKER; B CELL LYMPHOMA; BINDING SITE; CHICKEN; CHROMATIN IMMUNOPRECIPITATION; CORRELATION ANALYSIS; DEFENSE MECHANISM; DNA BINDING; HODGKIN DISEASE; HUMAN; HUMAN CELL; IN VIVO CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFORMATION; LYMPHOID CELL; MICROARRAY ANALYSIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; CHICKENS; CHROMATIN; DNA; DOWN-REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS V-REL; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-REL; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 38849106942     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-3169     Document Type: Article

References (63)

1. Zhang JY, Olson W, Ewert D, Bargmann W, Bose HR, Jr. The v-rel oncogene of avian reticuloendotheliosis virus transforms immature and mature lymphoid cells of the B cell lineage in vitro. Virology 1991;183:457-66.
2. Hrdlickova R, Nehyba J, Humphries EH. In vivo evolution of c-rel oncogenic potential. J Virol 1994;68:2371-82.
3. Nehyba J, Hrdlickova R, Humphries EH. Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation. J Virol 1994;68:2039-50.
4. Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 2001;20:7098-103.
5. Romieu-Mourez R, Kim DW, Shin SM, et al. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 2003;23:5738-54.
6. Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 2005;115:2625-32.
7. Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 2004;23:2275-86.
8. Barth TF, Martin-Subero JI, Joos S, et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 2003;101:3681-6.
9. Feuerhake F, Kutok JL, Monti S, et al. NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005;106:1392-9.
10. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003;102:3871-9.
11. Weniger MA, Gesk S, Ehrlich S, et al. Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein. Genes Chromosomes Cancer 2007;46:406-15.
12. Bargou R, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-9.
13. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001;194:1861-74.
14. Wu M, Lee H, Bellas RE, et al. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996;15:4682-90.
15. Fan Y, Rayet B, Gélinas C. Divergent C-terminal transactivation domains of Rel/NF-kB proteins are critical determinants of their oncogenic potential in lymphocytes. Oncogene 2004;23:1030-42.
16. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. Current insights into the regulation of programmed cell death by NF-kB. Oncogene 2006;25:6800-16.
17. Kralova J, Liss AS, Bargmann W, Bose HR, Jr. AP-1 factors play an important role in transformation induced by the v-rel oncogene. Mol Cell Biol 1998;18:2997-3009.
18. Hrdlickova R, Nehyba J, Bose HR, Jr. Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. Mol Cell Biol 2001;21:6369-86.
19. Kralova J, Liss AS, Bargmann W, et al. Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel. J Virol 2002;76:11960-70.
20. Hrdlickova R, Nehyba J, Liss AS, Bose HR, Jr. Mechanism of telomerase activation by v-Rel and its contribution to transformation. J Virol 2006;80:281-95.
21. Majid SM, Liss AS, You M, Bose HR. The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene 2006;25:756-68.
22. Neiman PE, Ruddell A, Jasoni C, et al. Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc Natl Acad Sci U S A 2001;98:6378-83.
23. Ishiai M, Kurosaki M, Pappu R, et al. BLNK required for coupling Syk to PLC γ2 and Rac1-JNK in B cells. Immunity 1999;10:117-25.
24. Fan Y, Gelinas C. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation. Oncogene 2007;26:4038-43.
25. Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. Transcription factor NF-kB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 2000;14:399-402.
26. Chen L, Lim MY, Bose H, J.M. B. Rearrangements of chicken immunoglobulin genes in lymphoid cells transformed by the avian retroviral oncogene v-rel. Proc Natl Acad Sci U S A 1988;85:549-53.
27. Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 2000;13:817-27.
28. Simeoni L, Kliche S, Lindquist J, Schraven B. Adaptors and linkers in T and B cells. Curr Opin Immunol 2004;16:304-13.
29. Flemming A, Brummer T, Reth M, Jumaa H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol 2003;4:38-43.
30. Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003;101:1505-12.
31. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2002;21:4908-20.
32. Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-κB. Cell Death Differ 2006;13:759-72.
33. Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-κB. Mol Cell 2004;13:853-65.
34. Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NF-κB transactivation by the ARF tumor suppressor. Mol Cell 2003;12:15-25.
35. Jiang HY, Petrovas C, Sonenshein GE. RelB-p50 NF-κ B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-κ B family members. J Virol 2002;76:5737-47.
36. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 2005;24:1157-69.
37. Campbell KJ, Witty JM, Rocha S, Perkins ND. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation. Cancer Res 2006;66:929-35.
38. Poppelmann B, Klimmek K, Strozyk E, Voss R, Schwarz T, Kulms D. NFκB-dependent down-regulation of tumor necrosis factor receptor-associated proteins contributes to interleukin-1-mediated enhancement of ultraviolet B-induced apoptosis. J Biol Chem 2005;280:15635-43.
39. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NFκB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006;103:12481-6.
40. Belvin MP, Anderson KV. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 1996;12:393-416.
41. Tumang JR, Owyang A, Andjelic S, et al. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur J Immunol 1998;28:4299-312.
42. Kontgen F, Grumont RJ, Strasser A, et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 1995;9:1965-77.
43. Owyang AM, Tumang JR, Schram BR, et al. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J Immunol 2001;167:4948-56.
44. Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999;13:400-11.
45. Grumont RJ, Rourke IJ, O'Reilly LA, et al. B lymphocytes differentially use the Rel and nuclear factor kB1 (NF-kB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med 1998;187:663-74.
46. Feng B, Cheng S, Hsia CY, King LB, Monroe JG, Liou HC. NF-κB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell Immunol 2004;232:9-20.
47. Tumang JR, Hsia CY, Tian W, Bromberg JF, Liou HC. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2. Cell Immunol 2002;217:47-57.
48. Tan JE, Wong SC, Gan SK, Xu S, Lam KP. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-κB and cell cycle entry and survival of B lymphocytes. J Biol Chem 2001;276:20055-63.
49. Yamazaki T, Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat Immunol 2003;4:780-6.
50. Beug H, Muller H, Doederlein G, Graf T. Hematopoietic cells transformed in vitro by REV-T avian reticuloendotheliosis virus express characteristics of very immature lymphoid cells. Virology 1981;115:295-309.
51. Boehmelt G, Madruga J, Dorfler P, et al. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell 1995;80:341-52.
52. Barth CF, Ewert DL, Olson WC, Humphries EH. Reticuloendotheliosis virus REV-T(REV-A)-induced neoplasia: development of tumors within the T-lymphoid and myeloid lineages. J Virol 1990;64:6054-62.
53. Barth CF, Humphries EH. Expression of v-rel induces mature B-cell lines that reflect the diversity of avian immunoglobulin heavy- and light-chain rearrangements. Mol Cell Biol 1988;8:5358-68.
54. Jumaa H, Mitterer M, Reth M, Nielsen PJ. The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Eur J Immunol 2001;31:2164-9.
55. Grabbe A, Wienands J. Human SLP-65 isoforms contribute differently to activation and apoptosis of B lymphocytes. Blood 2006;108:3761-8.
56. Papa S, Bubici C, Zazzeroni F, et al. The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ 2006;13:712-29.
57. White DW, Roy A, Gilmore TD. The v-Rel oncoprotein blocks apoptosis and proteolysis of IκB-α in transformed chicken spleen cells. Oncogene 1995;10:857-68.
58. White DW, Gilmore TD. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of IκB-α in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene 1996;13:891-9.
59. Bellas RE, Lee JS, Sonenshein GE. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest 1995;96:2521-7.
60. Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC. c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 2002;14:905-16.
61. Cheng S, Hsia CY, Leone G, Liou H-C. Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel-/- B cells. Oncogene 2003;22:8472-86.
62. Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann ML. Biology of Hodgkin's lymphoma. Ann Oncol 2002;13 Suppl 1:11-8.
63. Gilmore TD, Jean-Jacques J, Richards R, Cormier C, Kim J, Kalaitzidis D. Stable expression of the avian retroviral oncoprotein v-Rel in avian, mouse, and dog cell lines. Virology 2003;316:9-16.